✦ LIBER ✦

An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial

✍ Scribed by Lickliter, Jason D.; Taylor, Kerry; Szer, Jeff; Grigg, Andrew; Arthur, Christopher; Hughes, Timothy P.; Durrant, Simon; Filshie, Robin; Irving, Ian; Seldon, Michael; Ellacott, Jennifer; Boyd, Andrew W.; D’Rozario, James; Rooney, Kim; Lynch, Kevin; Bradstock, Ken

Book ID: 127295175
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 630 KB
Volume: 56
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2014.925547

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN45 COST EFFECTIVENESS OF ADDING IMATI

PCN45 COST EFFECTIVENESS OF ADDING IMATINIB TO CHEMOTHERAPY IN ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL):AN EXPLORATORY ANALYSIS FOR THE UK

✍ MF Botteman; KT Tran; JM Stephens 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Impact of age, leukocyte count and day 2

Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study

✍ Virginie Gandemer; Marie-Francoise Auclerc; Yves Perel; Jean-Pierre Vannier; Edo 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 521 KB

Intermediate dose of imatinib in combina

Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005

✍ Susana Rives; Jesús Estella; Pedro Gómez; Mónica López-Duarte; Purificación Garc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB